Samsung Rasagiline Tablet 0.5 mg (Rasagiline Mesylate)

Adult dose

This medicine is administered orally once daily to adults as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If it is well tolerated and an adequate clinical response is not achieved, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This medication should not be used in certain patients. Individuals allergic to the active ingredient or other components of this medication should not take it. Furthermore, it can be dangerous when taken with other MAO inhibitors or certain analgesics, cold medications, etc. Therefore, it should not be used in patients currently taking these medications or those who have stopped using them within the last 2 weeks. Patients with moderate to severe liver function impairment should also not take this medication. Side effects can occur when taking this medication. Symptoms such as headache, dizziness, nausea, insomnia, muscle pain, joint pain, skin rash, rhinitis, and angina are commonly reported. Moreover, psychological symptoms such as depression or hallucinations have also been noted. Other adverse reactions may include blood disorders, infections, gastrointestinal issues, and kidney problems. Consult a healthcare professional immediately if any symptoms appear. This medication should be used with caution in patients with liver dysfunction, and severe liver impairment patients should not take it. For patients with slight kidney dysfunction, dosage adjustment is not necessary; however, safety has not been confirmed in severe renal impairment cases. Drowsiness or sudden sleep symptoms may occur during treatment; therefore, avoid driving or operating machinery during these symptoms. Additionally, this medication may cause increased drowsiness when taken with other central nervous system depressants or alcohol, so caution is advised. This medication has many drug interactions; particularly, it can be dangerous when taken with other MAO inhibitors, specific analgesics, antidepressants, cold medicines, and sympathomimetics. Therefore, it is crucial to inform your doctor or pharmacist of any other medications you are taking. Pregnant or breastfeeding women should take caution when using this medication. If breastfeeding, it may affect milk production; therefore, consult a professional for guidance. The safety and efficacy in children under 18 have not been established, and no special dosage adjustment is necessary for individuals over 65. In the case of overdose, severe side effects may occur, and appropriate treatment should be sought immediately at a medical facility. This medication should be kept out of reach of children and stored in a sealed container to protect it from air and moisture. Additionally, it should be stored in a cool place at temperatures between 1 to 25 degrees Celsius and should not be transferred to another container.

• Influenza
• skin cancer
• leukopenia
• allergy
• loss of appetite
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a sealed container to protect it from air and moisture. Furthermore, it should be kept in a cool place between 1 to 25 degrees Celsius to maintain its effectiveness.

Appearance

Flat, round tablets with edges, white or almost white in color

Package unit

30 tablets/bottle